Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 166

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 166
---
, at the Company’s election, the number of shares of common stock to be issued will be rounded up to the nearest whole number or the Company will pay a cash adjustment in an amount equal to such fraction multiplied by the exercise price. Transferability Subject to applicable laws, a pre -fundedwarrant may be transferred at the option of the holder upon surrender of the pre -fundedwarrants to us together with the appropriate instruments of transfer. Trading Market There is no trading market available for the pre -fundedwarrants on any securities exchange or nationally recognized trading system, and we do not expect a trading market to develop. We do not intend to list the pre -fundedwarrants on any securities exchange or nationally recognized trading market. Without a trading market, the liquidity of the pre -fundedwarrants will be extremely limited. The shares of common stock issuable upon exercise of the pre -fundedwarrants are currently traded on the Nasdaq. Right as a Shareholder Except as otherwise provided in the pre -fundedwarrants or by virtue of such holder’s ownership of shares of common stock, the holders of the pre -fundedwarrants do not have the rights or privileges of holders of our shares of common stock, including any voting rights, until they exercise their pre -fundedwarrants. The pre -fundedwarrants will provide that holders have the right to participate in distributions or dividends paid on our shares of common stock. Fundamental Transaction In the event of a fundamental transaction, as described in the pre -fundedwarrants and generally including any reorganization, recapitalization or reclassification of our shares of common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding shares of common stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding shares of common stock, the holders of the pre -fundedwarrants will be entitled to receive upon exercise of the pre -fundedwarrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the pre -fundedwarrants immediately prior to such fundamental transaction on a net exercise basis. 107 Our Transfer Agent and Warrant Agent The transfer agent and warrant agent is and will be Continental Stock Transfer & Trust Company. Anti-Takeover Effects of the Charter and Bylaws and Certain Provisions of